Cost-effectiveness of the addition of early hormonal therapy in locally advanced prostate cancer - results decisively determined by the cut-off time-point chosen for the analysis

By Neymark N.   Adriaenssen I.   Gorlia T.   Caleo S.   Bolla M.   Brochon D.  

European Journal of Cancer, Vol. 37, Iss. 14, 2001-09 ,pp. : 1768-1774

Elsevier

Access to resources Recommend Favorite

The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer

By See William   Tyrrell Chris  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 1, 2006-08 ,pp. : 7-16

Springer Publishing Company

Access to resources Recommend Favorite

The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer

By See William   Tyrrell Chris  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 13, 2006-08 ,pp. : 7-16

Springer Publishing Company

Access to resources Recommend Favorite

Chemo-radiotherapy for Locally Advanced Head and Neck Cancer--Long-term Results of a Phase II Trial

By Dinges S.   Budach V.   Stuschke M.   Budach W.   Boehmer D.   Schrader M.   Jahnke K.   Sack H.  

European Journal of Cancer, Vol. 33, Iss. 7, 1997-06 ,pp. : 1152-1155

Elsevier

Access to resources Recommend Favorite

Report on the quality of life analysis from the phase III trial of pion versus photon radiotherapy in locally advanced prostate cancer

By Duncan G.G.   Philips N.   Pickles T.  

European Journal of Cancer, Vol. 36, Iss. 6, 2000-04 ,pp. : 759-765

Elsevier

Access to resources Recommend Favorite